Increased risk of hip fracture among older people using antidepressant drugs: Data from the Norwegian Prescription Database and the Norwegian Hip Fracture Registry

Age and Ageing

Volumn 42, Issue 4, 2013, Pages 514-520

  Bakken, Marit Stordal ^a,b   Engeland, Anders ^b,c   Engesæter, Lars B ^b,d   Ranhoff, Anette Hylen ^a,b   Hunskaar, Steinar ^b   Ruths, Sabine ^b,e  

^a STATOIL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e Uni Research   (Norway)

Author keywords

Antidepressants; Hip fractures; Older people; Pharmacoepidemiology; Population registers

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; MIANSERIN; MIRTAZAPINE; MOCLOBEMIDE; NORTRIPTYLINE; PAROXETINE; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; VENLAFAXINE;

AGED; ARTICLE; ATTRIBUTABLE RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE REGISTRY; DRUG EXPOSURE; DRUG INFORMATION; FEMALE; HIP FRACTURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NORWAY; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ANTIDEPRESSANTS; HIP FRACTURES; OLDER PEOPLE; PHARMACOEPIDEMIOLOGY; POPULATION REGISTERS;

AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DRUG PRESCRIPTIONS; FEMALE; HIP FRACTURES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NORWAY; PHARMACOEPIDEMIOLOGY; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 84879854667     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/aft009     Document Type: Article

References (30)

1. Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Ogelsby AK. International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 2002; 17: 1237-44.
2. Leibson CL, Tosteson AN, Gabriel SE, Ransom JE, Melton LJ. Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study. J Am Geriatr Soc 2002; 50: 1644-50.
3. Cumming RG, Nevitt MC, Cummings SR. Epidemiology of hip fractures. Epidemiol Rev 1997; 19: 244-57.
4. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 1999; 47: 30-9.
5. Wu Q, Liu J, Gallegos-Orozco JF, Hentz JG. Depression, fracture risk, and bone loss: a meta-analysis of cohort studies. Osteoporos Int 2010; 21: 1627-35.
6. Department of pharmacoepidemiology, Norwegian Institute of Public Health. Drug Consumption in Norway 2006-2010. Oslo: Norwegian Institute of Public Health, 2011.
7. Hansen DG, Rosholm JU, Gichangi A, Vach W. Increased use of antidepressants at the end of life: population-based study among people aged 65 years and above. Age Ageing 2007; 36: 449-54.
8. Pratt LA, Brody DJ, Gu Q. Antidepressant use in persons aged 12 and over: United States, 2005-2008. Hyattsville, MD: National Center for Health Statistics, 2011 (NCHS Data Breif, No 76).
9. Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ 2011; 343: d4551.
10. van den Brand MW, Pouwels S, Samson MM et al. Use of anti-depressants and the risk of fracture of the hip or femur. Osteoporos Int 2009; 20: 1705-13.
11. Hubbard R, Farrington P, Smith C, Smeeth L, Tattersfield A. Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture. Am J Epidemiol 2003; 158: 77-84.
12. Coupland CA, Dhiman P, Barton G et al. A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database. Health Technol Assess 2011; 15: 1-202. , iii-iv.
13. Richards JB, Papaioannou A, Adachi JD et al. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 2007; 167: 188-94.
14. Norwegian Prescription Database. http://www.norpd.no. (November 2012).
15. Gjertsen JE, Engesaeter LB, Furnes O et al. The Norwegian Hip Fracture Register: experiences after the first 2 years and 15,576 reported operations. Acta Orthop 2008; 79: 583-93.
16. Norwegian Central Population Registry: http://www. folkeregistret.no/. (November 2012).
17. Furu K. Establishment of the nationwide Norwegian Prescription Database. Nor J Epidemiol 2008; 18: 129-36.
18. The WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atc_ddd_index/. (November 2012).
19. Lingjærde O. Psykofarmaka. Medikamentell behandling av psykiske lidelser. 5. utg. (Psychotropic drugs: pharmaceutical treatment of mental disorders) Oslo: Høyskoleforlaget, 2006.
20. Engeland A, Skurtveit S, Morland J. Risk of road traffic accidents associated with the prescription of drugs: a registrybased cohort study. Ann Epidemiol 2007; 17: 597-602.
21. Vestergaard P, Rejnmark L, Mosekilde L. Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int 2006; 17: 807-16.
22. Bolton JM, Metge C, Lix L, Prior H, Sareen J, Leslie WD. Fracture risk from psychotropic medications: a populationbased analysis. J Clin Psychopharmacol 2008; 28: 384-91.
23. Wu Q, Bencaz AF, Hentz JG, Crowell MD. Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies. Osteoporos Int 2012; 23: 365-75.
24. Bolton JM, Targownik LE, Leung S, Sareen J, Leslie WD. Risk of low bone mineral density associated with psychotropic medications and mental disorders in postmenopausal women. J Clin Psychopharmacol 2011; 31: 56-60.
25. Haney EM, Warden SJ, Bliziotes MM. Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management? Bone 2010; 46: 13-7.
26. Darowski A, Chambers SA, Chambers DJ. Antidepressants and falls in the elderly. Drugs Aging 2009; 26: 381-94.
27. Kannegaard PN, van der Mark S, Eiken P, Abrahamsen B. Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival. Age Ageing 2010; 39: 203-9.
28. Ruths S, Sørensen PH, Kirkevold O et al. Trends in psychotropic drug prescribing in Norwegian nursing homes from 1997 to 2009: a comparison of six cohorts. Int J Geriatr Psychiatry 2012 Nov (Epub ahead of print, November 2012).
29. Schneeweiss S, Wang PS. Association between SSRI use and hip fractures and the effect of residual confounding bias in claims database studies. J Clin Psychopharmacol 2004; 24: 632-8.
30. Lesen E, Petzold M, Andersson K, Carlsten A. To what extent does the indicator "concurrent use of three or more psychotropic drugs" capture use of potentially inappropriate psychotropics among the elderly? Eur J Clin Pharmacol 2009; 65: 635-42.